Journal
AMERICAN JOURNAL OF PATHOLOGY
Volume 163, Issue 5, Pages 1937-1947Publisher
ELSEVIER SCIENCE INC
DOI: 10.1016/S0002-9440(10)63552-3
Keywords
-
Categories
Ask authors/readers for more resources
Connective tissue growth factor (CTGF) has been described as a novel fibrotic mediator. CTGF is over-expressed in several kidney diseases and is induced by different factors involved in renal injury. Angiotensin H (AngII) participates in the pathogenesis of kidney damage, contributing to fibrosis; however, whether AngII regulates CTGF in the kidney has not been explored. Systemic infusion of AngII into normal rats for 3 days increased renal CTGF mRNA and protein levels. At day 7, AngII-infused rats presented overexpression of CTGF in glomeruli, tubuli, and renal arteries, as welt as tubular injury and elevated fibronectin deposition. Only treatment with an AT, receptor antagonist, but not an AT(2), diminished CTGF and fibronectin overexpression and ameliorated tubular damage. In rats with immune complex nephritis, renal overexpression of CTGF was diminished by the ACE inhibitor quinapril, correlated with a diminution in fibrosis. In cultured renal cells (mesangial and tubular epithelial cells) AngII, via AT,, increased CTGF mRNA and protein production, and a CTGF antisense oligonucleotide decreased AngII-induced fibronectin synthesis. Our data show that AngII regulates CTGF in the kidney and cultured in mesangial and tubular cells. This novel finding suggests that CTGF could be a mediator of the profibrogenic effects of AngII in the kidney.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available